10.01.20

Review on Flavin-Dependent Halogenase Biocatalysis accepted in "Catalysts"

“Recent Advances in Flavin-Dependent Halogenase Biocatalysis: Sourcing, Engineering, and Application” a review written by Johannes Büchler, Athena Papadopoulou and Rebecca Buller is now available in “Catalysts”.

08.10.19

Publication in «Angewandte Chemie»

«Evolved Aliphatic Halogenases Enable Regiocomplementary C‐H Functionalization of an Added‐Value Chemical» is accepted for publication in «Angewandte Chemie»

24.09.19

Enzymatic PET Degradation

«Enzymatic PET Degradation» a review article by Athena Papadopoulou, Katrin Hecht and Rebecca Buller is part of special issue on Green and Sustainable Chemistry (Chimia 73 (2019) 743–749).

29.08.19

Microbial Epimerases: A toolbox for the synthesis of novel peptide-based drugs

Antibiotic resistance has increased steadily in recent years. Could peptides - organic chemical compounds made up of amino acids - contribute to the solution?

07.03.19

New Innosuisse Funding

Christin Peters together with Prof. Donald Hilvert (ETH) and Prof. Mark Tibbitt (ETH) received funding within Innosuisse «Manufacturing technologies» impulse programme (Projekt 35545.1 IP-LS)

14.02.19

Publication in CHEMBIOCHEM

Additional ene reductases have been added to our biocatalytic toolbox! For more information check «Novel Old Yellow Enzyme Subclasses» just published in CHEMBIOCHEM.

19.12.18

Bookchapter in «Pharmaceutical Biocatalysis»

«Ene Reductases in Pharmaceutical Chemistry» a bookchapter for «Pharmaceutical Biocatalyis» (Pan Stanford Publishing), contributed by Katrin Hecht and Rebecca Buller is accepted for publication

19.12.18

Review in Current Opinion in Biotechnology

«Directed Evolution of Carbon-Hydrogen Bond Activating Enzymes» a review by Raphael Frey, Takahiro Hayashi and Rebecca Buller is accepted for publication at «Current Opinion in Biotechnology».

27.02.18

Collaboration with Novartis Pharma AG

«Biocatalytic oxidation processes with alpha-ketoglutarate dependent enzymes for sustainable chemical synthesis» with Partner Novartis Pharma AG was approved by the CTI (CTI 28385.1 PFLS-LS)

26.02.18

Rebecca Buller will speak at the SwissCat Seminar «Catalysis Across Scales»

«Harnessing nature: biocatalysis for development and drug discovery» is the title of the talk

19.02.18

CHIMIA article on «Innovation in Biocatalysis – A Swiss Network Project Coordinated by the Competence Center for Biocatalysis (CCBIO)»

The project «Innovation in Biocatalysis» aims to create a network for dynamic and innovative biocatalysis in Switzerland.

08.01.18

Rebecca Buller has been elected as new Swiss representative on the ESAB scientific board

Rebecca Buller (ZHAW) has been elected as new Swiss representative on the scientific board of the European Section of Applied Biocatalysis.

19.07.17

Biocatalysis at Basel Life - Speakers and Topics

The final program of the session Biocatalysis brought by NTN Swiss Biotech is now available.

31.05.17

Meet CCBIO at Basel LIFE 2017: «Biocatalysis is brought by NTN Swiss Biotech»

Within the Innovation Forums on September 13, 2017 the session «Biocatalysis is brought by NTN Swiss Biotech» will take place. We are happy to announce speakers and topics.

05.05.17

An der ZHAW entsteht ein «Innovationsraum Biokatalyse»

Das an der ZHAW in Wädenswil angesiedelte Kompetenzzentrum für Biokatalyse (CCBIO) unter der Leitung von Dr. Rebecca Buller wird vom Bund mit zwei Millionen Franken für den Aufbau eines «Innovationsraums Biokatalyse» unterstützt. Projektpartner…

20.06.16

Industrielle Biokatalyse

Das Kompetenzzentrum für Biokatalyse - eine neue Plattform zur Förderung von Wissen- und Technologietransfer zwischen Hochschule und Industrie - stellte sich im Rahmen des 8th Wädenswil Day of Life Sciences vor.